Announcements Trials
Browse Landscape

Phase

Phase 1/2 9Phase 2 7Phase NA 2Phase 3 2Phase 4 1Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 2Other hematologic neoplasm 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 60Leukemia, Myeloid, Acute 40Leukemia 30Leukemia, Myelogenous, Chronic, BCR-ABL Positive 28Hematologic Neoplasms 23Leukemia, Lymphocytic, Chronic, B-Cell 16Lymphoma 11Febrile Neutropenia 10Myelodysplastic Syndromes 9Recurrence 8Neoplasms 8Lymphoma, Non-Hodgkin 8Leukemia, Myeloid, Chronic-Phase 8Leukemia, Promyelocytic, Acute 7Neoplasm, Residual 6Neutropenia 5Neoplasms, Plasma Cell 4Graft vs Host Disease 4Philadelphia Chromosome 3Mycoses 3Lymphoma, Mantle-Cell 3Leukemia, B-Cell 3Invasive Fungal Infections 3Bronchiolitis Obliterans Syndrome 3Blast Crisis 3Waldenstrom Macroglobulinemia 2Vomiting 2Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Tumor Lysis Syndrome 2

Interventions

obinutuzumab 1acalabrutinib 1Rituximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Lymphatic Diseases × Other hematologic neoplasm × Clear all
NCT06651970 2026-05-18

Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure

AstraZeneca

Phase 4 Recruiting
60 enrolled
LymphoidOther hematologic neoplasm

Heart Failure, Lymphatic Diseases, Leukemia, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡